(19)
(11) EP 0 682 526 A1

(12)

(43) Date of publication:
22.11.1995 Bulletin 1995/47

(21) Application number: 94909571.0

(22) Date of filing: 08.02.1994
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 9/ 12( . )
A61K 38/ 00( . )
A61K 38/ 43( . )
A61P 9/ 10( . )
A61P 11/ 08( . )
A61P 29/ 00( . )
A61P 31/ 04( . )
A61P 37/ 06( . )
C12N 5/ 10( . )
C12R 1/ 91( . )
A61K 9/ 00( . )
A61K 9/ 72( . )
A61K 38/ 17( . )
A61P 9/ 00( . )
A61P 11/ 00( . )
A61P 25/ 00( . )
A61P 31/ 00( . )
A61P 37/ 00( . )
C07K 14/ 705( . )
C12P 21/ 02( . )
(86) International application number:
PCT/US1994/001405
(87) International publication number:
WO 1994/017822 (18.08.1994 Gazette 1994/19)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 12.02.1993 US 19930016918

(71) Applicants:
  • T CELL SCIENCES, INC.
    Cambridge, MA 02139-4135 (US)
  • THE REGENTS OF THE UNIVERSITY OF MINNESOTA
    Minneapolis, Minnesota 55455 (US)

(72) Inventors:
  • LEVIN, James L.
    Wellesley, MA 02181 (US)
  • REGAL, Jean F.
    Duluth, MN 55803 (US)
  • TOTH, Carol A.
    Sharon, MA 0267 (US)

(74) Representative: Müller-Boré & Partner Patentanwälte 
Grafinger Strasse 2
D-81671 München
D-81671 München (DE)

   


(54) PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS